13. BARETTINO D, VIVANCO RUIZ MM, AND STUNNENBERG HG. Characterization of the ligand-dependent transactivation domain of thyroid
hormone receptor. EMBO J 13: 3039 –3049, 1994.
14. BARROS AC, ERWAY LC, KREZEL W, CURRAN T, KASTNER P, CHAMBON P,
AND FORREST D. Absence of thyroid hormone receptor beta-retinoid
X receptor interactions in auditory function and in the pituitarythyroid axis. Neuroreport 9: 2933–2937, 1998.
15. BARROSO I, GURNELL M, CROWLEY VE, AGOSTINI M, SCHWABE JW, SOOS
MA, MASLEN GL, WILLIAMS TD, LEWIS H, SCHAFER AJ, CHATTERJEE VK,
AND O'RAHILLY S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus
and hypertension. Nature 402: 880 – 883, 1999.
16. BARTSCH J, TRUSS M, BODE J, AND BEATO M. Moderate increase in
histone acetylation activates the mouse mammary tumor virus
promoter and remodels its nucleosome structure. Proc Natl Acad
Sci USA 93: 10741–10746, 1996.
17. BEATO M, HERRLICH P, AND SCHUTZ G. Steroid hormone receptors:
many actors in search of a plot. Cell 83: 851– 857, 1995.
18. BEATO M AND SANCHEZ-PACHECO A. Interaction of steroid hormone
receptors with the transcription initiation complex. Endocr Rev 17:
587– 609, 1996.
19. BEDO G, SANTISTEBAN P, AND ARANDA A. Retinoic acid regulates
growth hormone gene expression. Nature 339: 231–234, 1989.
20. BELANDIA B, LATASA MJ, VILLA A, AND PASCUAL A. Thyroid hormone
negatively regulates the transcriptional activity of the beta-amyloid
precursor protein gene. J Biol Chem 273: 30366 –30371, 1998.
21. BELIKOV S, GELIUS B, ALMOUZNI G, AND WRANGE O. Hormone activation induces nucleosome positioning in vivo. EMBO J 19: 1023–
1033, 2000.
22. BERKENSTAM A, RUIZ MM, BARETTINO D, HORIKOSHI M, AND STUNNENBERG HG. Cooperativity in transactivation between retinoic acid
receptor and TFIID requires an activity analogous to E1A. Cell 69:
401– 412, 1992.
23. BEVAN CL, HOARE S, CLAESSENS F, HEERY DM, AND PARKER MG. The
AF1 and AF2 domains of the androgen receptor interact with
distinct regions of SRC1. Mol Cell Biol 19: 8383– 8392, 1999.
24. BIGLER J AND EISENMAN RN. Novel location and function of a thyroid
hormone response element. EMBO J 14: 5710 –5723, 1995.
25. BIRD AP AND WOLFFE AP. Methylation-induced repression— belts,
braces, and chromatin. Cell 99: 451– 454, 1999.
26. BLANCO JC, MINUCCI S, LU J, YANG XJ, WALKER KK, CHEN H, EVANS
RM, NAKATANI Y, AND OZATO K. The histone acetylase PCAF is a
nuclear receptor coactivator. Genes Dev 12: 1638 –1651, 1998.
27. BLANCO JC, WANG IM, TSAI SY, TSAI MJ, O'MALLEY BW, JURUTKA PW,
HAUSSLER MR, AND OZATO K. Transcription factor TFIIB and the
vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 92: 1535–1539, 1995.
28. BODENNER DL, MROCZYNSKI MA, WEINTRAUB BD, RADOVICK S, AND
WONDISFORD FE. A detailed functional and structural analysis of a
major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene. J Biol Chem 266: 21666 –21673, 1991.
29. BOURGUET W, RUFF M, CHAMBON P, GRONEMEYER H, AND MORAS D.
Crystal structure of the ligand-binding domain of the human nu- clear receptor RXR-alpha. Nature 375: 377–382, 1995.
30. BOURGUET W, VIVAT M, WURTZ V, CHAMBON P, GRONEMEYER H, AND
MORAS D. Crystal structure of a heterodimeric complex of RAR and
RXR ligand-binding domains. Mol Cell 5: 289 –298, 2000.
31. BRUGGEMEIER U, KALFF M, FRANKE S, SCHEIDEREIT C, AND BEATO M.
Ubiquitous transcription factor OTF-1 mediates induction of the
MMTV promoter through synergistic interaction with hormone re- ceptors. Cell 64: 565–572, 1991.
32. BRZOZOWSKI AM, PIKE AC, DAUTER Z, HUBBARD RE, BONN T, ENGSTROM
O, OHMAN L, GREENE GL, GUSTAFSSON JA, AND CARLQUIST M. Molecular basis of agonism and antagonism in the oestrogen receptor.
Nature 389: 753–758, 1997.
33. BUGGE TH, POHL J, LONNOY O, AND STUNNENBERG HG. RXR alpha, a
promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 11: 1409 –1418, 1992.
34. BUSCH K, MARTIN B, BANIAHMAD A, MARTIAL JA, RENKAWITZ R, AND
MULLER M. Silencing subdomains of v-ErbA interact cooperatively
with corepressors: involvement of helices 5/6. Mol Endocrinol 14:
201–211, 2000.
35. CAELLES C, GONZALEZ-SANCHO JM, AND MUN~ OZ A. Nuclear hormone
